Rucaparib: A Review in Ovarian Cancer-Reference-Cited by-同舟云学术

Rucaparib: A Review in Ovarian Cancer

Published:2019-03-04 Issue:2 Volume:14 Page:237-246
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Shirley Matt

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-019-00629-5.pdf

Reference40 articles.

1. International Agency for Research on Cancer. Cancer Today; 2019. http://gco.iarc.fr/today/home . Accessed 22 Jan 2019.

2. Ledermann JA, Raja FA, Fotopoulou C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24–32.

3. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32.

4. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–15.

5. National Comprehensive Cancer Network®. NCCN clinical practice guidelines in oncology (NCCN Guidelines®): ovarian cancer including fallopian tube cancer and primary peritoneal cancer (version 2.2018); 2018. http://www.nccn.org . Accessed 07 Feb 2019.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship;European Journal of Medicinal Chemistry;2024-08

2. Ovarian cancer: Diagnosis and treatment strategies (Review);Oncology Letters;2024-07-18

3. Selective Construction of C–S/S–N Bonds from N-Substituted O-Thiocarbamates and Indoles under Transition-Metal-Free Conditions;The Journal of Organic Chemistry;2024-02-29

4. Pharmacovigilance study of Rucaparib based on the FDA Adverse Event Reporting System(FAERS);2023-12-08

5. DNA repair pathways in breast cancer: from mechanisms to clinical applications;Breast Cancer Research and Treatment;2023-06-08